All Stories

  1. PotentEx VivoActivity of Naphthoquine and Methylene Blue against Drug-Resistant Clinical Isolates of Plasmodium falciparum and Plasmodium vivax

    Article • Antimicrobial Agents and Chemotherapy, July 2015, ASM Journals

    Dr Jutta Marfurt

  2. ContrastingEx VivoEfficacies of “Reversed Chloroquine” Compounds in Chloroquine-Resistant Plasmodium falciparum and P. vivax Isolates

    Article • Antimicrobial Agents and Chemotherapy, July 2015, ASM Journals

    Dr Jutta Marfurt

  3. Preserved Dendritic Cell HLA-DR Expression and Reduced Regulatory T Cell Activation in Asymptomatic Plasmodium falciparum and P. vivax Infection

    Article • Infection and Immunity, June 2015, ASM Journals

    Dr Jutta Marfurt

  4. Contrasting Transmission Dynamics of Co-endemic Plasmodium vivax and P. falciparum: Implications for Malaria Control and Elimination

    Article • PLoS Neglected Tropical Diseases, May 2015, PLOS

    Dr Jutta Marfurt

  5. Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum

    Article • Nature Communications, November 2014, Springer Science + Business Media

    Dr Jutta Marfurt, Dr Natalie J. Spillman

  6. Effective Preparation of Plasmodium vivax Field Isolates for High-Throughput Whole Genome Sequencing

    Article • PLoS ONE, January 2013, PLOS

    Dr Jutta Marfurt

  7. Phenotypic and genotypic characterisation of drug-resistant Plasmodium vivax

    Article • Trends in Parasitology, November 2012, Elsevier

    Dr Jutta Marfurt

  8. A Prospective Comparative Study of Knowlesi, Falciparum, and Vivax Malaria in Sabah, Malaysia: High Proportion With Severe Disease From Plasmodium Knowlesi and Plasmodium Vivax But No Mortality With Early Referral and Artesunate Therapy

    Article • Clinical Infectious Diseases, October 2012, Oxford University Press (OUP)

    Dr Jutta Marfurt

  9. An Analytical Method for Assessing Stage-Specific Drug Activity in Plasmodium vivax Malaria: Implications for Ex Vivo Drug Susceptibility Testing

    Article • PLoS Neglected Tropical Diseases, August 2012, PLOS

    Dr Jutta Marfurt

  10. ComparativeEx VivoActivity of Novel Endoperoxides in Multidrug-Resistant Plasmodium falciparum and P. vivax

    Article • Antimicrobial Agents and Chemotherapy, July 2012, ASM Journals

    Dr Jutta Marfurt

  11. Ex VivoDrug Susceptibility of Ferroquine against Chloroquine-Resistant Isolates of Plasmodium falciparum and P. vivax

    Article • Antimicrobial Agents and Chemotherapy, July 2011, ASM Journals

    Dr Jutta Marfurt

  12. Ex VivoActivity of Histone Deacetylase Inhibitors against Multidrug-Resistant Clinical Isolates ofPlasmodium falciparumandP. vivax

    Article • Antimicrobial Agents and Chemotherapy, December 2010, ASM Journals

    Dr Jutta Marfurt

  13. In VivoandIn VitroEfficacy of Chloroquine againstPlasmodium malariaeandP. ovalein Papua, Indonesia

    Article • Antimicrobial Agents and Chemotherapy, October 2010, ASM Journals

    Dr Jutta Marfurt

  14. In Vitro Activity of Pyronaridine against Multidrug-Resistant Plasmodium falciparum and Plasmodium vivax

    Article • Antimicrobial Agents and Chemotherapy, September 2010, ASM Journals

    Dr Jutta Marfurt

  15. Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance

    Article • Malaria Journal, January 2010, Springer Science + Business Media

    Dr Jutta Marfurt

  16. Evaluation of Plasmodium vivax Genotyping Markers for Molecular Monitoring in Clinical Trials

    Article • The Journal of Infectious Diseases, April 2009, Oxford University Press (OUP)

    Dr Jutta Marfurt

  17. In Vivo and In Vitro Efficacy of Amodiaquine Monotherapy for Treatment of Infection by Chloroquine-Resistant Plasmodium vivax

    Article • Antimicrobial Agents and Chemotherapy, December 2008, ASM Journals

    Dr Jutta Marfurt

  18. Molecular Markers of In Vivo Plasmodium vivax Resistance to Amodiaquine Plus Sulfadoxine‐Pyrimethamine: Mutations in pvdhfr and pvmdr1

    Article • The Journal of Infectious Diseases, August 2008, Oxford University Press (OUP)

    Dr Jutta Marfurt

  19. Heterogeneous distribution of Plasmodium falciparum drug resistance haplotypes in subsets of the host population

    Article • Malaria Journal, January 2008, Springer Science + Business Media

    Dr Jutta Marfurt

  20. Identification and Differentiation of Leishmania Species in Clinical Samples by PCR Amplification of the Miniexon Sequence and Subsequent Restriction Fragment Length Polymorphism Analysis

    Article • Journal of Clinical Microbiology, July 2003, ASM Journals

    Dr Jutta Marfurt

  21. Diagnostic genotyping of Old and New World Leishmania species by PCR-RFLP

    Article • Diagnostic Microbiology and Infectious Disease, June 2003, Elsevier

    Dr Jutta Marfurt

  22. The Mechanism of Loss of CR1 during Maturation of Erythrocytes Is Different between Factor I Deficient Patients and Healthy Donors

    Article • Blood Cells Molecules and Diseases, September 2002, Elsevier

    Dr Jutta Marfurt

  23. Lack of occurrence of severe lupus nephritis among anti-C1q autoantibody-negative patients

    Article • Arthritis & Rheumatism, January 1999, Wiley

    Dr Jutta Marfurt

  24. Sequence and diversity of T-cell receptor alpha V , J , and C genes of the owl monkey Aotus nancymaae

    Article • Immunogenetics, August 1998, Springer Science + Business Media

    Dr Jutta Marfurt

  25. Generation of chimeric monoclonal antibodies from mice that carry human immunoglobulin Cγ1 heavy or Cκ light chain gene segments

    Article • Journal of Immunological Methods, June 1998, Elsevier

    Dr Jutta Marfurt